Genomenon, Inc logo

Genomenon, Inc

Genomic intelligence for clinical diagnostics and precision medicine development

151 employees · est. 2014 · Ann Arbor, United States

VS
Pathway Pharmaceuticals logo

Pathway Pharmaceuticals

Innovative precision medicine for personalized cancer treatment through advanced molecular analysis and comprehensive clinical trials review.

11-50 employees · est. 2014

Genomenon, Inc is the larger of the two.

Side-by-Side Comparison

Genomenon, Inc Pathway Pharmaceuticals
Founded
2014 2014
Headquarters
Ann Arbor, United States Not tracked yet
Employees
151 larger 11-50
Industry
Developer Tools, Enterprise Software Biotechnology, Health Care
Funding Stage
Series Unknown Seed
Total Funding
$38.23M Not tracked yet
Funding Rounds
9 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Genomics, Pharmaceuticals, Clinical Diagnostics, Software Tools, Genetic Diagnostics, Bioinformatics, Oncology, Next Generation Sequencing, DNA, Rare Diseases, Precision Medicine, Genomic Research Precision Medicine, Cancer Treatment, Molecular Analysis, Genomics, Bioinformatics, Clinical Trials, Transcriptomics, Targeted Therapeutics, Medical Review Committee, Personalized Treatment, Systems Biology, Biochemistry, Clinical Data Analysis, Medical Technology, Data Integration
Website
genomenon.com pathwaypharmaceuticals.com
Genomenon, Inc logo

About Genomenon, Inc

Genomenon, Inc is a leading genomic intelligence company founded in 2014, with the mission to enhance patients’ lives by identifying the genomic drivers of genetic disease and cancer. Their slogan, "Genomic intelligence for clinical diagnostics and precision medicine development," encapsulates their...

Pathway Pharmaceuticals logo

About Pathway Pharmaceuticals

Pathway Pharmaceuticals is a biotechnology and healthcare startup founded in 2014. The company specializes in innovative precision medicine for personalized cancer treatment through advanced molecular analysis and comprehensive clinical trials review. Their slogan, "Innovative precision medicine for...

We will tell you when either one moves

BounceWatch watches Genomenon, Inc and Pathway Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Genomenon, Inc and Pathway Pharmaceutical... — by email.

Frequently Asked Questions

Genomenon, Inc — Genomic intelligence for clinical diagnostics and precision medicine development. Pathway Pharmaceuticals — Innovative precision medicine for personalized cancer treatment through advanced molecular analysis and comprehensive clinical trials review.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Genomenon, Inc has raised $38.23M while Pathway Pharmaceuticals has raised undisclosed funding.
Genomenon, Inc and Pathway Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Genomenon, Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genomenon, Inc on 11 Sep 2024, and Pathway Pharmaceuticals on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes